YUMANITY THERAPEUTICS INC's ticker is YMTX and the CUSIP is 98872L102. A total of 31 filers reported holding YUMANITY THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $67,000 | -15.2% | 43,185 | 0.0% | 0.00% | – |
| Q2 2022 | $79,000 | -22.5% | 43,185 | -36.1% | 0.00% | – |
| Q1 2022 | $102,000 | -51.2% | 67,564 | -4.2% | 0.00% | – |
| Q4 2021 | $209,000 | -71.0% | 70,530 | +0.9% | 0.00% | – |
| Q3 2021 | $721,000 | -5.4% | 69,905 | +6.9% | 0.00% | – |
| Q2 2021 | $762,000 | -34.7% | 65,409 | +1.5% | 0.00% | – |
| Q1 2021 | $1,167,000 | +26.0% | 64,431 | +18.3% | 0.00% | – |
| Q4 2020 | $926,000 | – | 54,469 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 108,847 | $1,850,000 | 1.42% |
| SPHERA FUNDS MANAGEMENT LTD. | 130,434 | $2,217,000 | 0.20% |
| HARBOURVEST PARTNERS LLC | 22,030 | $375,000 | 0.15% |
| Redmile Group, LLC | 611,003 | $10,387,000 | 0.13% |
| Ikarian Capital, LLC | 132,514 | $2,253,000 | 0.10% |
| Artal Group S.A. | 217,391 | $3,696,000 | 0.08% |
| Maven Securities LTD | 43,478 | $739,000 | 0.07% |
| Bain Capital Public Equity Management II, LLC | 31,331 | $533,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 14,498 | $246,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11,000 | $187,000 | 0.00% |